T-Hub collaborates with Novartis
Hyderabad, Feb 9 (INN): T-Hub, India's fastest growing start-up engine, has signed a Memorandum of Understanding (MoU) with pharmaceutical major Novartis Healthcare Private Ltd (NHPL) to create and execute joint programs that would benefit Health Tech startups from across segments.
Being leaders in healthcare, Novartis will be working together with T-Hub to develop plans and programs that will help health tech, health care and pharmaceutical startups to scale and grow. As a part of the initiatives health, research and development experts from Novartis will mentor and guide startups, in compliance with T-Hub's mentorship framework and evaluation process, in their respective ventures.
The MoU will help foster a close relationship in these areas while contributing towards the building of a thriving ecosystem in Hyderabad. Headquartered in Basel, Switzerland, Novartis has a significant footprint in India with a strong base in Hyderabad through its Global Drug Development and Business Services Center.
Speaking about the partnership, Jay Krishnan, CEO, T-Hub said, 'We are very excited to collaborate with Novartis, a world class leader in healthcare. Novartis will bring great value to the ecosystem and HealthTech startups will be greatly benefited. With HealthTech being one of our prime sectors, we are working towards ensuring that startups associated with T-Hub are well mentored and guided through various programs of ours, which will help them scale their business faster.'
Subodh Deshmukh, Global Drug Development India Head, Novartis said, 'As a global leader in biomedical innovation, we are excited about this potential partnership with T-Hub and its allied startups driving innovation in the healthcare space.'
Hyderabad, Feb 9 (INN): T-Hub, India's fastest growing start-up engine, has signed a Memorandum of Understanding (MoU) with pharmaceutical major Novartis Healthcare Private Ltd (NHPL) to create and execute joint programs that would benefit Health Tech startups from across segments.
Being leaders in healthcare, Novartis will be working together with T-Hub to develop plans and programs that will help health tech, health care and pharmaceutical startups to scale and grow. As a part of the initiatives health, research and development experts from Novartis will mentor and guide startups, in compliance with T-Hub's mentorship framework and evaluation process, in their respective ventures.
The MoU will help foster a close relationship in these areas while contributing towards the building of a thriving ecosystem in Hyderabad. Headquartered in Basel, Switzerland, Novartis has a significant footprint in India with a strong base in Hyderabad through its Global Drug Development and Business Services Center.
Speaking about the partnership, Jay Krishnan, CEO, T-Hub said, 'We are very excited to collaborate with Novartis, a world class leader in healthcare. Novartis will bring great value to the ecosystem and HealthTech startups will be greatly benefited. With HealthTech being one of our prime sectors, we are working towards ensuring that startups associated with T-Hub are well mentored and guided through various programs of ours, which will help them scale their business faster.'
Subodh Deshmukh, Global Drug Development India Head, Novartis said, 'As a global leader in biomedical innovation, we are excited about this potential partnership with T-Hub and its allied startups driving innovation in the healthcare space.'
News Posted: 9 February, 2017
|
